Topic

New York

A collection of 498 issues

How to Get Zokinvy (lonafarnib) Covered by UnitedHealthcare in New York: Complete Appeal Guide

Quick Answer: Getting Zokinvy Covered by UnitedHealthcare in New York UnitedHealthcare requires prior authorization for Zokinvy (lonafarnib) with specific genetic testing requirements. For HGPS patients, you need confirmed diagnosis only. For progeroid laminopathies, you must document heterozygous LMNA mutation with progerin-like protein accumulation OR homozygous/compound heterozygous ZMPSTE24 mutations. Submit
6 min read

Renewing Hetlioz (Tasimelteon) Approval with UnitedHealthcare in New York: Complete 2025 Timeline and Documentation Guide

Answer Box: Hetlioz Renewal with UnitedHealthcare in New York UnitedHealthcare requires annual prior authorization renewal for Hetlioz (tasimelteon), with documentation of positive clinical response. Submit renewal 30 days before expiration via the UnitedHealthcare Provider Portal with updated sleep diaries showing continued benefit. If denied, file internal appeal within 180 days,
5 min read

How to Get StrataGraft Covered by UnitedHealthcare in New York: Prior Authorization Guide with Appeals Process and Documentation Requirements

Quick Answer: Getting StrataGraft Approved by UnitedHealthcare in New York UnitedHealthcare requires prior authorization for StrataGraft (allogeneic cultured keratinocytes & fibroblasts in murine collagen-dsat) under the medical benefit, not pharmacy. Submit via the UHC Provider Portal with burn depth documentation, TBSA calculations, and proof of failed standard therapies. Standard decisions
7 min read

Renewing Therakos CELLEX Photopheresis Coverage with UnitedHealthcare in New York: Timeline, Documentation & Appeal Options

Answer Box: Fast Track to Renewal Therakos CELLEX photopheresis renewal with UnitedHealthcare requires prior authorization renewal before your current approval expires. Submit renewal requests 10-14 days before expiration via the UHC provider portal with updated clinical documentation showing treatment response. For CTCL or GVHD patients, include response assessments, lab monitoring
5 min read

Aetna (CVS Health) Coverage Criteria for Ultomiris (ravulizumab) in New York: What Counts as "Medically Necessary"?

Answer Box: Getting Ultomiris Covered by Aetna (CVS Health) in New York Ultomiris (ravulizumab) requires prior authorization from Aetna (CVS Health) for all FDA-approved indications (PNH, aHUS, anti-AChR+ generalized myasthenia gravis, and NMOSD). Coverage requires meeting diagnosis-specific criteria, meningococcal vaccination, and documentation of clinical necessity. Quick start: 1) Verify your
5 min read